18F-fluoromisonidazole positron emission tomography before treatment is a predictor of radiotherapy outcome and survival prognosis in patients with head and neck squamous cell carcinoma. - Wikidata - wikimedia - TriplyDB

18F-fluoromisonidazole positron emission tomography before treatment is a predictor of radiotherapy outcome and survival prognosis in patients with head and neck squamous cell carcinoma.

18F-fluoromisonidazole positron emission tomography before treatment is a predictor of radiotherapy outcome and survival prognosis in patients with head and neck squamous cell carcinoma.

http://www.wikidata.org/entity/Q53216205

about

Imaging tumour hypoxia with positron emission tomography Positron emission tomography to assess hypoxia and perfusion in lung cancer Integrating Imaging Data into Predictive Biomathematical and Biophysical Models of Cancer Molecular mechanisms of hypoxia in cancer.PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence Hypoxia in head and neck cancer in theory and practice: a PET-based imaging approach Hypoxia as a biomarker for radioresistant cancer stem cells.Evaluation of hypoxia in a feline model of head and neck cancer using ⁶⁴Cu-ATSM positron emission tomography/computed tomography.F-18 fluoromisonidazole for imaging tumor hypoxia: imaging the microenvironment for personalized cancer therapy Imaging hypoxia to improve radiotherapy outcome.Modelling tumour oxygenation, reoxygenation and implications on treatment outcome.Role of (18)F-FDG PET-CT in head and neck squamous cell carcinoma Molecular PET imaging for biology-guided adaptive radiotherapy of head and neck cancer.Hypoxia in Head and Neck Tumors: Characteristics and Development during Therapy.Molecular imaging of tumor hypoxia with positron emission tomography.The role of necrosis, acute hypoxia and chronic hypoxia in (18)F-FMISO PET image contrast: a computational modelling study.Tumor hypoxia: a new PET imaging biomarker in clinical oncology.The role of PET/CT in the management of patients affected by head and neck tumors: a review of the literature.A review of the predictive role of functional imaging in patients with mucosal primary head and neck cancer treated with radiation therapy.Quantification of Tumor Hypoxic Fractions Using Positron Emission Tomography with [18F]Fluoromisonidazole ([18F]FMISO) Kinetic Analysis and Invasive Oxygen Measurements.Hypoxia as a Biomarker and for Personalized Radiation Oncology.MiR-210 links hypoxia with cell proliferation regulation in human Laryngocarcinoma cancer.Dynamic contrast-enhanced MR imaging in predicting progression of enhancing lesions persisting after standard treatment in glioblastoma patients: a prospective study.Robustness of quantitative hypoxia PET image analysis for predicting local tumor control.Glioma FMISO PET/MR Imaging Concurrent with Antiangiogenic Therapy: Molecular Imaging as a Clinical Tool in the Burgeoning Era of Personalized Medicine.

P2860

Q26851422-329FCAEE-E9AB-41AD-B595-93E218E51546 Q27026940-E7F73AB9-40A1-4E93-BE7C-2AB7D5389782 Q30659261-B2F65A67-AD57-4B57-BDE0-876517756BB6 Q33705108-871A7299-71F4-4E0C-8CB6-D85A12CEBA79 Q33818999-B8AABF9B-0264-498D-B189-EF4FB970CF4E Q34151551-90C5B990-B1E9-4F1E-AAC5-1A605F798BB5 Q34420732-D25AB4CC-8F13-432C-9447-0726F9905ADC Q34696310-5B17A3E7-9479-4DD6-950F-34562F35E020 Q35116993-4EE79581-C682-46D0-9D47-55EAAC4D2A33 Q38059626-CECDBCDA-5BF8-42A4-A9F3-EFF521FD79AB Q38080844-4DEB6050-A7A6-415C-98D2-1C4AE5E12AFE Q38101933-C083C650-0691-48F4-BD17-C6F5FDF3274C Q38134094-C3D21B2F-AFA5-4ED0-84A2-3F49BCC88451 Q38134761-EA74770C-4044-410C-943C-F9666B743E26 Q38199721-32C4BFE4-AEE1-490A-986A-9437A4EF6F67 Q38404220-4DF65A18-EE0D-492B-A507-F39939C1390B Q38411275-DC513469-A1E6-48D4-893C-5D7D1BD7A774 Q38478344-75D951AB-FA82-472E-A686-52BD71413BCD Q38836743-48E373FD-C834-4FF0-AD39-9552A3BD7732 Q38837272-5D3DE749-F9CC-4F73-A476-532B47DA45F3 Q38869433-115E74CE-CFBE-458C-A0E4-F1ACBE1DB171 Q38914407-B8669F4B-E46C-4BA5-8956-62ADADD6DE44 Q51079367-01514668-75E4-4D37-860C-2010D2F73DC6 Q52990174-D97C56F3-94A5-4202-8B74-DC8101D23C94 Q53109990-73F30A16-DAF9-4CD3-BA38-B29D784AFBAF

P2860

18F-fluoromisonidazole positron emission tomography before treatment is a predictor of radiotherapy outcome and survival prognosis in patients with head and neck squamous cell carcinoma.

http://www.wikidata.org/entity/Q53216205

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

18F-fluoromisonidazole positro ...... neck squamous cell carcinoma.

@en

18F-fluoromisonidazole positro ...... neck squamous cell carcinoma.

@nl

type

label

18F-fluoromisonidazole positro ...... neck squamous cell carcinoma.

@en

18F-fluoromisonidazole positro ...... neck squamous cell carcinoma.

@nl

prefLabel

18F-fluoromisonidazole positro ...... neck squamous cell carcinoma.

@en

18F-fluoromisonidazole positro ...... neck squamous cell carcinoma.

@nl

P1433

Q53216205-5A4B2076-60C4-4025-988E-812965211823

P1476

Q53216205-A0C81225-36A9-49B8-86A0-C1FEC20EAF67

P2093

Q53216205-0BD45993-5680-49A4-B360-895D8007F5B0

Q53216205-19D90154-F063-4EDF-A273-ED242E291EF1

Q53216205-6878297B-86C9-4D68-8A86-FF942EC63D25

Q53216205-82ABE188-29D9-4608-B400-0B5291EA38B8

Q53216205-A732B903-AD66-499C-B359-C6D47A96376E

Q53216205-AFC352A1-1C0B-4521-AD46-8AD36396363D

Q53216205-D7BB552C-2364-4AF4-BAE6-BC2ABDF651E0

P2860

Q53216205-01770FC4-87E5-4751-A934-2473C8545B8F

Q53216205-0194EC68-CEDB-4219-8F9C-FAEA166AA37E

Q53216205-14E8F134-0E44-416D-B21D-D8C60FB2D6DB

Q53216205-1F9715BD-2DD2-47A1-814E-50317093CB6C

Q53216205-4367910C-5033-483B-BD75-10C8B22529C5

Q53216205-66941601-08AA-48AD-AAB9-BB5764144B8D

Q53216205-735C985B-4A8F-4D82-833C-66C72E2E43C2

Q53216205-84953AA4-0208-48FB-BD2D-F821F292FC01

Q53216205-96D957ED-743A-4477-B55F-CBA5003B8A4A

Q53216205-99463FBC-F2AB-4C7C-9E15-2F0442025B34

P2888

Q53216205-70E1175F-8BDC-4484-B9BF-5F12539110EF

P304

Q53216205-D468342D-F61E-4978-B5F9-4EF3C70766ED

P31

Q53216205-05562983-257C-46ED-A30F-69DFE12493BE

P356

Q53216205-E74D9D21-DD9A-457C-9D37-D3AB73755277

P433

Q53216205-58D09DA7-8438-4EF0-A49C-58FA88DDBA19

P478

Q53216205-7B1049E4-E3A2-4059-AC7C-9A4A663C378C

P50

Q53216205-7A4021C2-475C-47EB-A631-58768C6936F6

Q53216205-AD0E0F26-9742-4CAE-B6DC-96E85F025282

P577

Q53216205-E4D0AB31-7ED1-43DB-B0E4-55E4786F536E

P5875

Q53216205-A74F1D4A-3FCE-42C1-B04E-7032DCA03931

P698

Q53216205-8752E35A-8A58-4799-8B4B-BC4A351155F3

P921

Q53216205-004DD837-447F-48CF-A3D0-22BC8E5D579A

P356

S12149-011-0508-9

P1433

Annals of Nuclear Medicine

P1476

18F-fluoromisonidazole positro ...... d neck squamous cell carcinoma

@en

P2093

Hiroshi Yamazaki

http://www.w3.org/2001/XMLSchema#string

Keizo Fujiwara

http://www.w3.org/2001/XMLSchema#string

Masahiro Kikuchi

http://www.w3.org/2001/XMLSchema#string

Michio Senda

http://www.w3.org/2001/XMLSchema#string

Shin-ya Hori

http://www.w3.org/2001/XMLSchema#string

Yasushi Naito

http://www.w3.org/2001/XMLSchema#string

Yosuke Tona

http://www.w3.org/2001/XMLSchema#string

P2860

A kinetic model for dynamic [18F]-Fmiso PET data to analyse tumour hypoxia.

Tumor angiogenesis and accessibility: role of vascular endothelial growth factor.

Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival

Hypoxia in human soft tissue sarcomas: adverse impact on survival and no association with p53 mutations.

Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy.

Review: implications of in vitro research on the effect of radiotherapy and chemotherapy under hypoxic conditions.

Hypoxic sensitizers--implications for radiation therapy.

Fully automated synthesis of [18F]fluoromisonidazole using a conventional [18F]FDG module.

Synthesis and biodistribution of 18F-labeled fluoronitroimidazoles: potential in vivo markers of hypoxic tissue.

Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer.

P2888

s12149-011-0508-9

P304

625-633

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12149-011-0508-9

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

Tomohiko Yamane

Shogo Shinohara

P577

2011-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51459211

http://www.w3.org/2001/XMLSchema#string

P698

21720778

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy